SpectraBase Spectrum ID |
2nF02mBp15k |
Name |
Fenproporex |
CAS Registry Number |
15686-61-0 |
Classification |
Pharmaceutical drug, anorectic |
Comments |
Spectrum verified by crosschecking against external libraries (two reference spectrum with similarity >= 99% found); Spectrum verified by independent measurements in external laboratories |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.14 (f) (4) |
DEA Controlled Substance Name |
Fenproporex |
DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
DEA Controlled Substances Code Number |
1575 |
DEA Schedule |
Schedule IV |
DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers |
Exact Mass |
188.131348523 u |
Formula |
C12H16N2 |
InChI |
InChI=1S/C12H16N2/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,9-10H2,1H3 |
InChIKey |
IQUFSXIQAFPIMR-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
188.274 g/mol |
Nominal Mass |
188 u |
Quality |
1000 |
Retention Index |
1510 |
SMILES |
C1(CC(NCCC#N)C)=CC=CC=C1 |
SPLASH |
splash10-0002-9000000000-0519256a03f398157b92 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
3-(1-Phenylpropan-2-ylamino)propanenitrile |
Technique |
GC/MS |
Wiley ID |
DD2024_008296 |